Skip to main content
Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: A new insight into the role of plasma fibrinogen in the development of metabolic syndrome from a prospective cohort study in urban Han Chinese population

Fig. 1

The incidence of MetS by quartiles of fibrinogen in whole participants (a) and in overweight (b), dyslipidemia (c), hypertension (d), and hyperglycemia (e) sub-cohorts in male and female. In whole participants (a), 853 of 3843 males and 322 of 2366 females developed MetS during follow-up; In overweight sub-cohort (b), 618 of 1952 males and 198 of 717 females developed MetS during follow-up; In dyslipidemia sub-cohort (c), 344 of 1313 males and 100 of 483 females developed MetS during follow-up; In hypertension sub-cohort (d), 332 of 961 males and 163 of 511 females developed MetS during follow-up; In hyperglycemia sub-cohort (e), 96 of 251 males and of 115 females developed MetS during follow-up

Back to article page